Unlock Advanced Pharmaceutical Synthesis with Key Intermediates
Discover high-purity chemical building blocks essential for cutting-edge drug development and research.
Get a Quote & SampleProduct Core Value
Tert-Butyl (2-((4-Amino-6-Chloropyrimidin-5-yl)Oxy)ethyl) (Methyl) Carbamate
This Tert-Butyl (2-((4-Amino-6-Chloropyrimidin-5-yl)Oxy)ethyl) (Methyl) Carbamate, identified by its CAS number 1787294-51-2, is a critical pharmaceutical intermediate. Its primary application lies in the synthesis of novel therapeutic agents, most notably as a precursor for Remibrutinib, a Bruton's Tyrosine Kinase (BTK) inhibitor used in treating various immune-mediated conditions. The product adheres to stringent quality standards, including GMP, ISO 9001, and FDA certifications, ensuring reliability for scientific research and development.
- High Purity Intermediate: This essential pharmaceutical intermediate for BTK inhibitors ensures the integrity of complex synthesis pathways, crucial for developing targeted therapies like Remibrutinib.
- Reliable for Custom Synthesis: As a key component in custom synthesis of C12H19ClN4O3, it offers researchers and manufacturers flexibility in creating specific molecular structures for drug discovery.
- Supports Remibrutinib Intermediate Synthesis: This compound is integral to the precise Remibrutinib intermediate synthesis, enabling the efficient production of this significant BTK inhibitor.
- Quality Assured Supplier: Backed by certifications like GMP and ISO 9001, Nanjing Xinbell Pharmaceutical Technology Co., Ltd. provides this vital chemical, ensuring quality for Nanjing Xinbell Pharmaceutical Technology Co., Ltd. intermediates used in demanding research applications.
Key Advantages
Enhanced Synthesis Efficiency
Utilizing high-grade pharmaceutical intermediates like Tert-Butyl (2-((4-Amino-6-Chloropyrimidin-5-yl)Oxy)ethyl) (Methyl) Carbamate streamlines the Remibrutinib intermediate synthesis, leading to more efficient drug development processes.
Guaranteed Quality and Compliance
With GMP, ISO 9001, and FDA certifications, this intermediate meets rigorous industry standards, making it a trusted choice for custom synthesis of C12H19ClN4O3 in regulated environments.
Critical for Targeted Therapies
As a vital pharmaceutical intermediate for BTK inhibitors, it plays a key role in the development of innovative treatments targeting specific cellular pathways, advancing medical research.
Key Applications
Pharmaceutical Research & Development
Essential for the synthesis of active pharmaceutical ingredients (APIs), particularly those targeting specific biological pathways, supporting drug discovery initiatives and advancing medicinal chemistry.
Chemical Synthesis
Serves as a building block in complex organic synthesis, enabling the creation of diverse chemical entities required for various scientific and industrial applications, including the precise custom synthesis of C12H19ClN4O3.
Active Pharmaceutical Ingredient (API) Manufacturing
A critical component in the manufacturing of APIs like Remibrutinib, ensuring high purity and quality for therapeutic compounds used in the healthcare sector.
Biotechnology and Life Sciences
Supports advancements in biotechnology and life sciences by providing reliable chemical components for research into new disease treatments and therapeutic modalities.